NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbf -SMMHC via activation of MEK/ERK axis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbf -SMMHC via activation of MEK/ERK axis
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 3, Pages 426-436
Publisher
American Society of Hematology
Online
2014-06-04
DOI
10.1182/blood-2013-12-541730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
- (2014) M. R. Corces-Zimmerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects
- (2013) Min Yang et al. ANNALS OF HEMATOLOGY
- NrasG12D/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions
- (2013) J. Wang et al. BLOOD
- Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic Transformation
- (2013) J. Xu et al. Cancer Discovery
- Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)
- (2012) P. Paschka et al. BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice
- (2012) Tiffany Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- N-RasG12D induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene
- (2011) F.-S. Chou et al. BLOOD
- GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway
- (2011) J. J. Wallin et al. MOLECULAR CANCER THERAPEUTICS
- Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells
- (2011) Xiongwei Cai et al. PLoS One
- A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice
- (2011) N. Lyubynska et al. Science Translational Medicine
- Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
- (2010) Q. Li et al. BLOOD
- Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia
- (2010) J. Wang et al. BLOOD
- AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
- (2010) C Haferlach et al. LEUKEMIA
- Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
- (2009) Jennifer O. Lauchle et al. NATURE
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Targeting Ras in Myeloid Leukemias
- (2008) B. S. Braun et al. CLINICAL CANCER RESEARCH
- M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience
- (2008) A. Pulsoni et al. HAEMATOLOGICA
- Cooperating gene mutations in acute myeloid leukemia: a review of the literature
- (2008) A Renneville et al. LEUKEMIA
- Multisite Phosphorylation Regulates Bim Stability and Apoptotic Activity
- (2008) Anette Hübner et al. MOLECULAR CELL
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
- Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
- (2008) A M S Müller et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More